• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[医源性骨质疏松症:六例病例报告]

[Iatrogenic osteoporsis: six case reports].

作者信息

Zheng L M, Wang J Z

机构信息

Tianjin Medical University.

出版信息

Zhonghua Nei Ke Za Zhi. 1994 Oct;33(10):658-60.

PMID:7712909
Abstract

Iatrogenic osteoporosis is a very common secondary osteoporosis is found in patients treated with large dosage of glucocorticosteroid of long duration. Six cases listed in this article including 2 cases of bronchial asthma, 2 cases of bronchial asthma, 2 cases of rheumatoid arthritis, 1 case of skin disease and 1 case of callagenosis (three male patients and three female patients). The age is from 27-46. The duration of treatment of primary disease with glucocorticosteroid is 1 to 3.5 years, with the average of 1.56 years. With the exception of one case treated with Dexamethasone one of 0.75g daily, the other 5 cases are treated with predinisone of 5-30mg daily. After they treated with hormone every other day and added Calcium and vitamin D and followed up 1 year, the mineral contents in the bone of all 6 patients are increased and the biochemistry indexes are improved.

摘要

医源性骨质疏松是一种非常常见的继发性骨质疏松,见于长期大剂量使用糖皮质激素治疗的患者。本文列举6例,其中支气管哮喘2例、类风湿关节炎2例、皮肤病1例、胶原病1例(男性3例,女性3例)。年龄27至46岁。原发性疾病使用糖皮质激素治疗的疗程为1至3.5年,平均1.56年。除1例每日服用0.75g地塞米松外,其他5例每日服用泼尼松5至30mg。在他们隔日使用激素并补充钙和维生素D并随访1年后,所有6例患者的骨矿物质含量均增加,生化指标得到改善。

相似文献

1
[Iatrogenic osteoporsis: six case reports].[医源性骨质疏松症:六例病例报告]
Zhonghua Nei Ke Za Zhi. 1994 Oct;33(10):658-60.
2
[Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].[用奈立膦酸治疗糖皮质激素诱导的骨质疏松症(GIOP)患者时骨吸收标志物的变化]
Recenti Prog Med. 2006 Jan;97(1):24-7.
3
Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.糖皮质激素诱导的早期炎症性关节炎性骨质疏松症预防性治疗的质量保证研究:CATCH 队列的结果。
Rheumatology (Oxford). 2012 Sep;51(9):1662-9. doi: 10.1093/rheumatology/kes079. Epub 2012 Apr 25.
4
Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years.类风湿性关节炎患者的骨质流失:来自一项基于人群的队列研究结果,该队列包含366名患者,随访两年。
Arthritis Rheum. 2002 Jul;46(7):1720-8. doi: 10.1002/art.10408.
5
Fractures in adults on systemic steroid therapy: which prophylaxis?接受全身类固醇治疗的成年人骨折:采取何种预防措施?
Prescrire Int. 1999 Oct;8(43):153-6.
6
Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.类风湿关节炎患者糖皮质激素诱导性骨质疏松的管理:学术性风湿病诊疗实践中的治疗率及预测因素
Arthritis Rheum. 2002 Dec;46(12):3136-42. doi: 10.1002/art.10613.
7
Effect of 1alpha-hydroxycholecalciferol in senile osteoporosis and in bone loss following prednisone treatment.
Isr J Med Sci. 1977 Mar;13(3):253-8.
8
Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.类风湿关节炎患者的骨质疏松管理:改善的证据。
Arthritis Rheum. 2006 Dec 15;55(6):873-7. doi: 10.1002/art.22350.
9
Bone loss in prednisone treated sarcoidosis: a two-year follow-up.泼尼松治疗结节病中的骨质流失:两年随访
Ann Ital Med Int. 1990 Jul-Sep;5(3 Pt 1):164-8.
10
Bone mineral density changes in women with systemic lupus erythematosus.系统性红斑狼疮女性的骨矿物质密度变化
Clin Rheumatol. 2003 Oct;22(4-5):318-23. doi: 10.1007/s10067-003-0743-0.